Delegates welcomed efforts to plan for a post-polio world, including WHO’s organization-widework to identify the key programmatic, financial, human resources and organizational risks associated with the eventual closure of the global polio eradication effort.
They requested the Director-General to consider polio transition planning an urgent organizational priority and highlighted the need to ensure that polio transition needs are fully incorporated into the development of the next WHO budget and planning cycle.
Delegates reaffirmed the critical role played by the Pandemic Influenza Preparedness Framework’s (PIP) as a specialized international instrument that facilitates expeditious access to influenza viruses of human pandemic potential, risk analysis and the expeditious, fair and equitable sharing of vaccines and other benefits.
They emphasized the importance of prioritizing and supporting global pandemic influenza preparedness and response, including through the strengthening of domestic seasonal influenza virussurveillance, manufacturing and regulatory capacities and international coordination and collaboration through the Global Influenza Surveillance and Response System (GISRS) to identify and share influenza viruses with pandemic potential rapidly.
The Health Assembly agreed that the WHO secretariat should comprehensively analyse, in consultation with Member States and relevant stakeholders, including the GISRS, the implications of amending the definition of PIP biological materials to include genetic sequence data and expanding the PIP Framework to include seasonal influenza.
9087
代表们进一步认为，大流行性流感防范框架模式有潜力用于其它病原体。
The delegates further agreed that the PIP Framework model has potential to be used for other pathogens.
9088
大流行性流感防范框架于2011年设立，以便在发生下一次流感大流行时在国家间有更高程度的公平和团结。
The PIP Framework was set up in 2011 to introduce greater equity and solidarity among nations when the next pandemic strikes.
The PIP Framework provides WHO with real-time access to approximately 10% of global vaccine production, enabling the Organization to send life-saving doses to developing countries in need.